INS and Insulin resistance: As expected, biochemical analyses indicated that MO patients had significantly higher levels of fasting glucose, insulin, homeostasis model assessment of insulin resistance (HOMA2-IR), glycated hemoglobin (HbA1c), systolic blood pressure (SBP) and diastolic blood pressure (DBP) (p < 0.05) than normal-weight subjects.